ACS
CELL

Archford Capital Strategies’s PhenomeX Inc. Common Stock CELL Stock Holding History

Archford Capital Strategies’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,059
Closed -$310K – 306
2021
Q4 		$310K Buy
17,059
+3,589
+27% +$77.5K 0.07% 238
2021
Q3 		$263K Buy
13,470
+8,681
+181% +$330K 0.06% 270
2021
Q2 		$215K Buy
+4,789
New +$222K 0.05% 286

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

Archford Capital Strategies's CELL Position: Q1 2022 in Review

Archford Capital Strategies sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2022, closing a stake of 17,059 shares — an estimated $310K sold.

Archford Capital Strategies first reported a position in CELL in Q2 2021 and held it in 3 quarters. The position peaked at $310K in Q4 2021. 130 funds tracked by Wall St. Rank hold CELL as of Q1 2022.

  • Archford Capital Strategies reported no remaining PhenomeX Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Archford Capital Strategies sold 17,059 PhenomeX Inc. Common Stock shares in Q1 2022, an estimated $310K.
  • Archford Capital Strategies first reported a position in PhenomeX Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • Archford Capital Strategies's PhenomeX Inc. Common Stock position peaked at $310K in Q4 2021.
  • 130 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2022.

Based on Archford Capital Strategies's 13F filing for Q1 2022, filed 18 Apr 2022.